TherapeuticsMD, Inc. SEC filings TXMD

TherapeuticsMD, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Jun 23, 2008. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

TherapeuticsMD, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Aug 11, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 11, 2026 Aug 11, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 5, 2026 —
10-Q Quarterly report May 12, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure
May 12, 2026 May 2, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 6, 2026 —
10-K/A Amended annual report Apr 1, 2026 Dec 31, 2025
NT 10-K Notification of late filing Apr 1, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Mar 30, 2026 Mar 30, 2026
10-K Annual report Mar 30, 2026 Dec 31, 2025
8-K Current report
Auditor change
Jan 21, 2026 Jan 15, 2026
4 Insider transaction Dec 29, 2025 Dec 23, 2025
8-K Current report
Shareholder vote results
Dec 16, 2025 Dec 15, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Nov 13, 2025 Nov 12, 2025
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
4 Insider transaction Nov 5, 2025 Nov 3, 2025
4 Insider transaction Nov 5, 2025 Nov 3, 2025
4 Insider transaction Nov 5, 2025 Nov 3, 2025
4 Insider transaction Nov 5, 2025 Nov 3, 2025
ARS Annual report to shareholders Nov 3, 2025 Dec 31, 2024
DEFA14A Additional proxy material Nov 3, 2025 —
DEF 14A Proxy statement Nov 3, 2025 Dec 15, 2025
PRE 14A Preliminary proxy statement Oct 24, 2025 Oct 24, 2025
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Aug 12, 2025 Aug 12, 2025
10-Q Quarterly report May 13, 2025 Mar 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
May 13, 2025 May 13, 2025
10-K/A Amended annual report Apr 30, 2025 Dec 31, 2024
4 Insider transaction Apr 15, 2025 Apr 14, 2025
4 Insider transaction Apr 15, 2025 Apr 14, 2025
4 Insider transaction Apr 10, 2025 Apr 9, 2025
8-K Current report
Other events
Apr 9, 2025 Apr 8, 2025
10-K Annual report Mar 27, 2025 Dec 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Mar 27, 2025 Mar 27, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
SCHEDULE 13G Ownership over 5% (passive) Feb 12, 2025 —
8-K Current report
Shareholder vote results
Dec 5, 2024 Dec 5, 2024
SC 13G Ownership over 5% (passive) Nov 12, 2024 —
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Nov 12, 2024 Nov 12, 2024
ARS Annual report to shareholders Oct 25, 2024 Dec 31, 2023
DEFA14A Additional proxy material Oct 25, 2024 —
DEF 14A Proxy statement Oct 25, 2024 Dec 5, 2024
8-K Current report Sep 20, 2024 Sep 20, 2024
4 Insider transaction Aug 26, 2024 Aug 22, 2024
4 Insider transaction Aug 23, 2024 Aug 21, 2024
10-Q Quarterly report Aug 12, 2024 Jun 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Aug 12, 2024 Aug 12, 2024
AW Amendment withdrawal request Jun 14, 2024 —
10-Q Quarterly report May 10, 2024 Mar 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
May 10, 2024 May 10, 2024
10-K/A Amended annual report Apr 29, 2024 Dec 31, 2023
10-K Annual report Mar 29, 2024 Dec 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Mar 29, 2024 Mar 29, 2024
4 Insider transaction Dec 7, 2023 Dec 5, 2023
144 Notice of proposed sale Dec 6, 2023 —
SC 13D/A Amended ownership over 5% (active) Nov 17, 2023 —
4 Insider transaction Nov 17, 2023 Nov 15, 2023
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Nov 14, 2023 Nov 14, 2023
4 Insider transaction Aug 21, 2023 Aug 17, 2023
3 Initial insider ownership Aug 21, 2023 Aug 17, 2023
8-K Current report
Material agreement, Officer or director change
Aug 18, 2023 Aug 15, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Aug 14, 2023 Aug 14, 2023
4 Insider transaction Jul 19, 2023 Jul 17, 2023
4 Insider transaction Jul 19, 2023 Jul 17, 2023
4 Insider transaction Jul 19, 2023 Jul 17, 2023
D Filing Jul 11, 2023 —
8-K Current report
Auditor change
Jul 10, 2023 Jul 7, 2023
8-K Current report
Unregistered share sale, Bylaw or fiscal year change
Jul 6, 2023 Jun 29, 2023
SC 13D/A Amended ownership over 5% (active) Jun 30, 2023 —
4 Insider transaction Jun 29, 2023 Jun 28, 2023
8-K Current report
Shareholder vote results
Jun 28, 2023 Jun 26, 2023
ARS Annual report to shareholders May 18, 2023 Dec 31, 2022
DEFA14A Additional proxy material May 17, 2023 —
DEF 14A Proxy statement May 17, 2023 Jun 26, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
May 15, 2023 May 15, 2023
8-K Current report
Material agreement
May 5, 2023 May 1, 2023
4/A Form 4/a submission May 4, 2023 Apr 12, 2023
PRE 14A Preliminary proxy statement May 1, 2023 Jun 26, 2023
10-K/A Amended annual report May 1, 2023 Dec 31, 2022
8-K Current report
Other events
Apr 21, 2023 Apr 21, 2023
4 Insider transaction Apr 14, 2023 Apr 12, 2023
4 Insider transaction Apr 14, 2023 Apr 12, 2023
10-K Annual report Apr 7, 2023 Dec 31, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Apr 7, 2023 Apr 7, 2023
NT 10-K Filing Mar 31, 2023 Dec 31, 2022
8-K Current report
Officer or director change
Feb 27, 2023 Feb 21, 2023
4 Insider transaction Feb 23, 2023 Feb 21, 2023
4 Insider transaction Feb 23, 2023 Feb 21, 2023
4/A Form 4/a Feb 22, 2023 Dec 30, 2022
5 Annual insider ownership Feb 13, 2023 Dec 31, 2022
4 Insider transaction Jan 30, 2023 Jan 26, 2023
4 Insider transaction Jan 25, 2023 Jan 23, 2023
8-K Current report
Officer or director change
Jan 18, 2023 Jan 11, 2023
8-K Current report
Listing notice
Jan 12, 2023 Jan 6, 2023
8-K/A Amended current report
Officer or director change
Jan 6, 2023 Dec 30, 2022
4 Insider transaction Jan 3, 2023 Dec 30, 2022
8-K Current report
Material agreement, Agreement ended, Acquisition or sale of assets, Officer or director change, Regulation FD disclosure, Other events
Jan 3, 2023 Dec 30, 2022
4 Insider transaction Dec 12, 2022 Dec 9, 2022
4 Insider transaction Dec 9, 2022 Dec 6, 2022
4 Insider transaction Dec 9, 2022 Dec 6, 2022
4 Insider transaction Dec 9, 2022 Dec 6, 2022
4 Insider transaction Dec 9, 2022 Dec 6, 2022
4 Insider transaction Dec 9, 2022 Dec 7, 2022
4 Insider transaction Dec 8, 2022 Dec 7, 2022
8-K Current report
Material agreement, Regulation FD disclosure
Dec 5, 2022 Dec 4, 2022
8-K Current report
Material agreement
Dec 1, 2022 Nov 30, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
D Filing Nov 14, 2022 —
8-K Current report
Results of operations, Regulation FD disclosure
Nov 14, 2022 Nov 14, 2022
4 Insider transaction Oct 31, 2022 Oct 28, 2022
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Oct 31, 2022 Oct 28, 2022
D Filing Oct 17, 2022 —
4 Insider transaction Oct 3, 2022 Sep 29, 2022
4 Insider transaction Oct 3, 2022 Sep 29, 2022
4 Insider transaction Oct 3, 2022 Sep 29, 2022
4 Insider transaction Oct 3, 2022 Sep 29, 2022
4 Insider transaction Oct 3, 2022 Sep 29, 2022
4 Insider transaction Oct 3, 2022 Sep 29, 2022
4 Insider transaction Oct 3, 2022 Sep 29, 2022
4 Insider transaction Oct 3, 2022 Sep 30, 2022
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Oct 3, 2022 Sep 30, 2022
3 Initial insider ownership Sep 16, 2022 Sep 6, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 12, 2022 Sep 6, 2022
3 Initial insider ownership Aug 31, 2022 Aug 23, 2022
SC 13D/A Amended ownership over 5% (active) Aug 30, 2022 —
8-K Current report
Officer or director change
Aug 29, 2022 Aug 23, 2022
4 Insider transaction Aug 22, 2022 Aug 18, 2022
4 Insider transaction Aug 22, 2022 Aug 18, 2022
4 Insider transaction Aug 22, 2022 Aug 18, 2022
4 Insider transaction Aug 22, 2022 Aug 18, 2022
4 Insider transaction Aug 22, 2022 Aug 18, 2022
4 Insider transaction Aug 22, 2022 Aug 18, 2022
4 Insider transaction Aug 22, 2022 Aug 18, 2022
D Filing Aug 16, 2022 —
10-Q Quarterly report Aug 15, 2022 Jun 30, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Aug 15, 2022 Aug 15, 2022
SC 13D Ownership over 5% (active) Aug 8, 2022 —
4 Insider transaction Aug 1, 2022 Jul 29, 2022
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Aug 1, 2022 Jul 29, 2022
8-K Current report
Material agreement
Jul 29, 2022 Jul 28, 2022
8-K Current report
Material agreement
Jul 28, 2022 Jul 27, 2022
8-K Current report
Material agreement, Other events
Jul 25, 2022 Jul 24, 2022
4 Insider transaction Jul 19, 2022 Jul 15, 2022
3 Initial insider ownership Jul 19, 2022 Jul 14, 2022
8-K Current report
Material agreement, Agreement ended
Jul 14, 2022 Jul 13, 2022
SC 14D9/A Filing Jul 13, 2022 —
SC TO-T/A Filing Jul 13, 2022 —
SC 13G/A Amended ownership over 5% (passive) Jul 8, 2022 —
SC 14D9/A Filing Jul 6, 2022 —
SC TO-T/A Filing Jul 6, 2022 —
SC 14D9/A Filing Jun 28, 2022 —
SC TO-T/A Filing Jun 23, 2022 —
SC 14D9 Filing Jun 13, 2022 —
SC TO-T Filing Jun 6, 2022 —
8-K/A Amended current report
Bylaw or fiscal year change
Jun 6, 2022 May 27, 2022
SC 13G Ownership over 5% (passive) Jun 3, 2022 —
8-K Current report
Material agreement
Jun 3, 2022 May 27, 2022
SC TO-C Filing May 31, 2022 —
SC14D9C Filing May 31, 2022 —
8-K Current report
Material agreement, Other events
May 31, 2022 May 27, 2022
8-K Current report
Regulation FD disclosure, Other events
May 20, 2022 May 20, 2022
10-Q Quarterly report May 16, 2022 Mar 31, 2022
8-K Current report
Results of operations, Regulation FD disclosure
May 16, 2022 May 16, 2022
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
May 9, 2022 May 3, 2022
10-K/A Amended annual report Apr 29, 2022 Dec 31, 2021
8-K Current report
Other events
Apr 27, 2022 Apr 27, 2022
8-K Current report
Acquisition or sale of assets
Apr 20, 2022 Apr 14, 2022
8-K Current report
Regulation FD disclosure
Apr 14, 2022 Apr 14, 2022
4 Insider transaction Mar 31, 2022 Mar 31, 2022
4 Insider transaction Mar 31, 2022 Mar 31, 2022
4 Insider transaction Mar 31, 2022 Mar 31, 2022
4 Insider transaction Mar 31, 2022 Mar 31, 2022
4 Insider transaction Mar 28, 2022 Mar 23, 2022
4 Insider transaction Mar 28, 2022 Mar 23, 2022
4 Insider transaction Mar 28, 2022 Mar 23, 2022
4 Insider transaction Mar 28, 2022 Mar 23, 2022
4 Insider transaction Mar 28, 2022 Mar 23, 2022
POS AM Filing Mar 24, 2022 —
10-K Annual report Mar 23, 2022 Dec 31, 2021
POSASR Filing Mar 23, 2022 —
SC 13D/A Amended ownership over 5% (active) Mar 23, 2022 —
8-K Current report
Listing notice, Officer or director change
Mar 18, 2022 Mar 14, 2022
4 Insider transaction Mar 15, 2022 Mar 14, 2022
8-K Current report
Material agreement, Results of operations, Regulation FD disclosure
Mar 10, 2022 Mar 6, 2022
8-K Current report
Regulation FD disclosure
Mar 7, 2022 Mar 7, 2022
8-K Current report
Officer or director change
Feb 18, 2022 Feb 17, 2022
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2022 —
SC 13G/A Amended ownership over 5% (passive) Feb 1, 2022 —
8-K Current report
Other events
Jan 3, 2022 Dec 28, 2021
8-K Current report
Officer or director change
Dec 20, 2021 Dec 14, 2021
8-K Current report
Officer or director change
Dec 17, 2021 Dec 13, 2021
8-K Current report
Regulation FD disclosure, Other events
Dec 10, 2021 Dec 10, 2021
8-K Current report
Regulation FD disclosure, Other events
Dec 8, 2021 Dec 7, 2021

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
TXMD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Boca Raton, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
25743
Former names
AMHN, Inc. (until Sep 14, 2011); CROFF ENTERPRISES INC (until Sep 4, 2009); CROFF OIL CO (until Apr 1, 1997)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.